Table 5.
AVF patency in dominant extremities | aspirin (%) | p - value | dipyridamol (%) | p-value | control (%) |
---|---|---|---|---|---|
Dominant | 30/42 (71.4%) | 0.8756 | 29/40 (72.5%) | 0.9365 | 26/39 (66.6%) |
Non-dominant | 60/88 (68.1%) | 0.9331 | 63/90 (76.6%) | 0.3042 | 63/91 (69.2%) |